Patents by Inventor Mark Sharkey

Mark Sharkey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of drug-resistant human immunodeficiency virus
    Patent number: 7232657
    Abstract: The invention relates to methods of detecting a drug resistant HIV in a subject. The methods include detecting mutations associated with drug resistance in an HIV 2-LTR circle DNA molecule obtained from a cell of an HIV-positive subject, e.g., an HIV-1-positive human.
    Type: Grant
    Filed: September 2, 2004
    Date of Patent: June 19, 2007
    Assignee: University of Massachusetts
    Inventors: Mario Stevenson, Mark Sharkey
  • Detection of drug-resistant human immunodeficiency virus
    Publication number: 20050042605
    Abstract: The invention relates to methods of detecting a drug resistant HIV in a subject. The methods include detecting mutations associated with drug resistance in an HIV 2-LTR circle DNA molecule obtained from a cell of an HIV-positive subject, e.g., an HIV-1-positive human.
    Type: Application
    Filed: September 2, 2004
    Publication date: February 24, 2005
    Inventors: Mario Stevenson, Mark Sharkey
  • Detection of drug-resistant human immunodeficiency virus
    Patent number: 6797464
    Abstract: The invention relates to methods of detecting a drug resistant HIV in a subject. The methods include detecting mutations associated with drug resistance in an HIV 2-LTR circle DNA molecule obtained from a cell of an HIV-positive subject, e.g, an HIV-1-positive human.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: September 28, 2004
    Assignee: University of Massachusetts
    Inventors: Mario Stevenson, Mark Sharkey
  • Detection of drug-resistant human immunodeficiency virus
    Publication number: 20040009124
    Abstract: The invention relates to methods of detecting a drug resistant HIV in a subject. The methods include detecting mutations associated with drug resistance in an HIV 2-LTR circle DNA molecule obtained from a cell of an HIV-positive subject, e.g, an HIV-1-positive human.
    Type: Application
    Filed: July 10, 2002
    Publication date: January 15, 2004
    Inventors: Mario Stevenson, Mark Sharkey
  • Endometrial function
    Publication number: 20030186907
    Abstract: Disclosed is a method of altering one or more characteristics of at least some of the cells of the reproductive tract of a mammalian individual by the introduction into said cells of a nucleic acid, together with a composition comprising nucleic acid, for use in the method.
    Type: Application
    Filed: September 24, 2002
    Publication date: October 2, 2003
    Applicant: Cambridge University Technical Services Limited
    Inventors: David Stephen Charnock-Jones, Stephen Kevin Smith, Andrew Mark Sharkey, Robert Brian Heap
  • Endometrial function
    Patent number: 6472374
    Abstract: Disclosed is a method of altering one or more characteristics of at least some of the cells of the reproductive tract of a mammalian individual by the introduction into said cells of a nucleic acid, together with a composition comprising nucleic acid, for use in the method.
    Type: Grant
    Filed: September 18, 1997
    Date of Patent: October 29, 2002
    Assignee: Cambridge University Technical Services Limited
    Inventors: David Stephen Charnock-Jones, Stephen Kevin Smith, Andrew Mark Sharkey, Robert Brian Heap
  • Human SCF, a splice variant thereof, its pharmaceutical use
    Patent number: 6177556
    Abstract: SCF which includes the following C-terminal sequence: Glu Ile Cys Ser Leu Leu Ile Gly Leu Thr Ala Tyr Lys Glu Leu Ser Leu Pro Lys Arg Lys Glu Thr Cys Arg Ala Ile Gln His Pro Arg Lys Asp or a C-terminal sequence which is substantially homologous thereto and its use in medicine, particularly in ensuring the correct development of pre-implantation embryos.
    Type: Grant
    Filed: July 31, 1997
    Date of Patent: January 23, 2001
    Assignee: Applied Research Systems ARS Holdings N.V.
    Inventors: Andrew Mark Sharkey, Stephen Kevin Smith, Kimberley Anne Dellow
  • FLT-4(FMS-like tyrosine kinase), FLT-15, variants thereof used as growth factor inhibitors
    Patent number: 6011003
    Abstract: Disclosed is an altered, soluble form of the FLT polypeptide being capable of binding to VEGF and thereby exerting an inhibitory effect thereon, the polypeptide comprising five or fewer complete immunoglobulin-like domains, together with pharmaceutical compositions comprising the polypeptide, and various uses thereof.
    Type: Grant
    Filed: May 12, 1997
    Date of Patent: January 4, 2000
    Assignee: Metris Therapeutics Limited
    Inventors: David Stephen Charnock-Jones, Christine Ann Boocock, Andrew Mark Sharkey, Stephen Kevin Smith